Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 7.92% is 156% above its 5-year average of -14.26%, near the high end of its 5-year range (-71.65%–20.16%).
14.44% above its 12-month average of 6.92%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 20.16%.
OPERATING MARGIN
7.92%
OPERATING MARGIN AVG TTM
6.92%
OPERATING MARGIN AVG 3Y
0.55%
OPERATING MARGIN AVG 5Y
-14.26%
OPERATING MARGIN AVG 10Y
-32.46%
OPERATING MARGIN AVG 15Y
-70.64%
OPERATING MARGIN AVG 20Y
-77.67%
CURRENT VS TTM AVG
+14.44%
CURRENT VS 3Y AVG
+1331.99%
CURRENT VS 5Y AVG
+155.53%
CURRENT VS 10Y AVG
+124.40%
CURRENT VS 15Y AVG
+111.21%
CURRENT VS 20Y AVG
+110.20%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 671 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$40.28M
Operating Margin
-380.85%
TTM Avg
-275.43%
3Y Avg
-246.44%
5Y Avg
-2168.10%
Market Cap
$38.97M
Operating Margin
1.17%
TTM Avg
-3.67%
3Y Avg
-2.94%
5Y Avg
-1.63%
Market Cap
$38.35M
Operating Margin
0.00%
TTM Avg
-13830.82%
3Y Avg
-69500.82%
5Y Avg
-46675.05%
Market Cap
$41.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$41.92M
Operating Margin
-5.63%
TTM Avg
-15.71%
3Y Avg
-54.38%
5Y Avg
-79.38%
Market Cap
$37.28M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-324.45%
Market Cap
$36.61M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-343.01%
Market Cap
$43.25M
Operating Margin
-90.49%
TTM Avg
-103.23%
3Y Avg
-126.36%
5Y Avg
-149.14%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nephros, Inc. (NEPH) | $39.90M | 7.92% | 6.92% | 0.55% | -14.26% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | -380.85% | -275.43% | -246.44% | -2168.10% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.97M | 1.17% | -3.67% | -2.94% | -1.63% |
| Incannex Healthcare Limited (IXHL)vs › | $38.35M | 0.00% | -13830.82% | -69500.82% | -46675.05% |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -5.63% | -15.71% | -54.38% | -79.38% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.28M | 0.00% | 0.00% | 0.00% | -324.45% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.61M | 0.00% | 0.00% | 0.00% | -343.01% |
| CVRx, Inc. (CVRX)vs › | $43.25M | -90.49% | -103.23% | -126.36% | -149.14% |
| DocGo Inc. (DCGO)vs › | $36.07M | -27.67% | -11.51% | -3.91% | -4.42% |
Gross Margin
60.3%
Operating Margin
7.9%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 20.16% |
| 2026-03-31 | 1.86% |
| 2025-12-31 | 0.38% |
| 2025-09-30 | 6.59% |
| 2025-06-30 | 5.61% |
| 2025-03-31 | 11.61% |
| 2024-12-31 | 8.19% |
| 2024-09-30 | 5.86% |
| 2024-06-30 | -9.75% |
| 2024-03-31 | -5.68% |
| 2023-12-31 | -19.94% |
| 2023-09-30 | -5.42% |
| 2023-06-30 | -12.27% |
| 2023-03-31 | -8.28% |
| 2022-12-31 | -27.09% |
| 2022-09-30 | -53.18% |
| 2022-06-30 | -28.56% |
| 2022-03-31 | -71.65% |
| 2021-12-31 | -37.54% |
| 2021-09-30 | -31.11% |
| 2021-06-30 | -49.29% |
| 2021-03-31 | -37.21% |
| 2020-12-31 | -30.81% |
| 2020-09-30 | -43.94% |
| 2020-06-30 | -101.33% |
| 2020-03-31 | -40.57% |
| 2019-12-31 | -9.21% |
| 2019-09-30 | -22.46% |
| 2019-06-30 | -37.59% |
| 2019-03-31 | -73.54% |
| 2018-12-31 | -45.22% |
| 2018-09-30 | -29.64% |
| 2018-06-30 | -47.80% |
| 2018-03-31 | -114.01% |
| 2017-12-31 | -31.00% |
| 2017-09-30 | -56.55% |
| 2017-06-30 | -81.49% |
| 2017-03-31 | -82.43% |
| 2016-12-31 | -81.74% |
| 2016-09-30 | -134.11% |
| 2016-06-30 | -160.51% |
| 2016-03-31 | -136.61% |
| 2015-12-31 | -183.17% |
| 2015-09-30 | -339.69% |
| 2015-06-30 | -104.76% |
| 2015-03-31 | -148.16% |
| 2014-12-31 | -230.99% |
| 2014-09-30 | -138.70% |
| 2014-06-30 | -144.22% |
| 2014-03-31 | -118.82% |
| 2013-12-31 | -384.07% |
| 2013-09-30 | -145.45% |
| 2013-06-30 | -109.22% |
| 2013-03-31 | -232.63% |
| 2012-12-31 | -302.17% |
| 2012-09-30 | -141.23% |
| 2012-06-30 | -268.87% |
| 2012-03-31 | -104.32% |
| 2011-12-31 | -131.08% |
| 2011-09-30 | -104.42% |
| 2011-06-30 | -93.88% |
| 2011-03-31 | -94.86% |
| 2010-12-31 | -116.83% |
| 2010-09-30 | -63.18% |
| 2010-06-30 | -45.24% |
| 2010-03-31 | -53.29% |
| 2009-12-31 | -66.79% |
| 2009-09-30 | -76.37% |
| 2009-06-30 | -112.71% |
| 2009-03-31 | -117.27% |
| 2008-12-31 | -213.41% |
| 2008-09-30 | -350.64% |
| 2008-06-30 | -1037.15% |
| 2008-03-31 | -458.91% |
| 2007-12-31 | -589.80% |
| 2007-09-30 | -1616.96% |
| 2007-06-30 | -445.11% |
| 2007-03-31 | -512.84% |
| 2006-12-31 | -1462.03% |
| 2006-09-30 | -1155.58% |
| 2006-06-30 | -724.97% |
| 2006-03-31 | -1196.45% |
| 2005-12-31 | -2772.55% |
| 2005-09-30 | -802.79% |
| 2005-06-30 | -925.16% |
| 2005-03-31 | -23.61% |
| 2004-12-31 | -2241.18% |
| 2004-09-30 | -4062.64% |
| 2004-06-30 | 0.00% |
